A. Mears

Induction and concurrent chemotherapy with high-dose thoracic conformal radiation therapy in unresectable stage IIIA and IIIB non-small-cell lung cancer: a dose-escalation phase I trial.

M. Socinski, F. Detterbeck, T. Hensing, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I/II trial of weekly docetaxel and gefitinib in elderly patients with stage IIIB/IV non-small cell lung cancer.

M. Socinski, T. Stinchcombe, P. Bůžková, 2006, Lung cancer.

Carboplatin-based chemotherapy in patients with advanced non-small cell lung cancer and a poor performance status.

M. Socinski, M. Schell, T. Stinchcombe, 2006, Lung cancer.

A randomized phase II trial comparing every 3-weeks carboplatin/paclitaxel with every 3-weeks carboplatin and weekly paclitaxel in advanced non-small cell lung cancer.

M. Socinski, J. Beaumont, A. Peterman, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Post-chemotherapy gross tumor volume is predictive of survival in patients with stage III non-small cell lung cancer treated with combined modality therapy.

M. Socinski, J. Rosenman, T. Stinchcombe, 2006, Lung cancer.

Phase I study of PTK787/ZK222584 (PTK/ZK) and RAD001 for patients with advanced solid tumors and dose expansion in renal cell carcinoma patients

A. Armstrong, H. Hurwitz, J. Bendell, 2007 .